Home/Recalls/FDA-D-0443-2026
FDA DrugsClass II

Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethy...

Published: April 15, 2026Recall ID: D-0443-2026Category: drugsCountry: US

Reason for Recall / Hazard

Lack of Assurance of Sterility

Product Description & Identification

Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles, Mfg: Geri-Care; Brooklyn, New York NDC 68788-7266-0

Additional Source Details

FieldValue
CityAnaheim
StateCA
Openfda › Nui › 1N0000185370
Openfda › Nui › 2N0000175629
Openfda › Nui › 3N0000184306
Openfda › Nui › 4N0000185001
Openfda › Nui › 5M0000728
Openfda › Nui › 6M0009417
Openfda › Unii › 1PDC6A3C0OX
Openfda › Unii › 23NXW29V3WO
Openfda › Unii › 3B697894SGQ
Openfda › RouteOPHTHALMIC
Openfda › Rxcui259581
Openfda › Spl id916ab19f-4424-41c3-af5e-d75ddddd2ba6
Openfda › Brand nameARTIFICIAL TEARS
Openfda › Spl set iddd646c72-8f47-43c6-a734-db0dcc8cd4d1
Openfda › Package ndc68788-7266-0
Openfda › Product ndc68788-7266
Openfda › Generic nameGLYCERIN
Openfda › Product typeHUMAN OTC DRUG
Openfda › Pharm class cs › 1Allergens [CS]
Openfda › Pharm class cs › 2Glycerol [CS]
Openfda › Pharm class pe › 1Increased Histamine Release [PE]
Openfda › Pharm class pe › 2Cell-mediated Immunity [PE]
Openfda › Pharm class pe › 3Increased IgG Production [PE]
Openfda › Substance name › 1GLYCERIN
Openfda › Substance name › 2HYPROMELLOSE, UNSPECIFIED
Openfda › Substance name › 3POLYETHYLENE GLYCOL 400
Openfda › Pharm class epcNon-Standardized Chemical Allergen [EPC]
Openfda › Manufacturer namePreferred Pharmaceuticals Inc.
Openfda › Application numberMO18
Openfda › Original packager product ndc57896-181
Event id98687
Address 11250 N Lakeview Ave Ste O
Code infoLot #: F1924R, F2024G, F2424E, G2424M, G2624P, J2424M
Postal code92807-1801
Report date20260415
Product typeDrugs
Product quantity720 bottles
Reason for recallLack of Assurance of Sterility
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20260325
Center classification date20260407

Overview

  • Recalling FirmPreferred Pharmaceuticals, Inc.
  • StatusOngoing
  • Risk LevelClass II
  • DistributionNationwide within the United States
Official Agency Alert